PHGE BiomX Inc. Gross Return on Sales

The gross margin chart demonstrates the efficiency of BiomX Inc. (PHGE) cold chain and diversified raw material supplies, with -691.90 serving as the base parameter value. The current share price already prices in R&D costs and asset integration while awaiting the results of phase two phage cocktail trials. Growth potential is based on strategic partnerships with institutions to create antibiotic alternatives.
Analytical breakdowns and data insights for company biomx.com (PHGE)

Gross margin measures production efficiency, reflecting the portion of revenue remaining after covering direct costs to form the base for operating activities. An analysis of the business's gross margins allows for an assessment of the resilience of BiomX Inc., whose revenues from phage therapy are independent of economic cycles and are instead determined by the success of clinical trials and patent protection.